The therapeutic effects of resveratrol have been shown in several diseases, such as inflammatory bowel disease (Shi et al, 2017) and neuroinflammation (Huang et al, 2021), by downregulating the enzymes and cytokines belonging to NF-κB signaling (Rahimifard et al, 2017). This evidence concerns the gene NFKB1 and inflammatory bowel disease.